Eye Diseases
Conditions
Interventions
Medical treatment for advanced glaucoma
Trans scleral diode laser cyclophotocoagulation for advanced glaucoma
Sponsors
Self
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed, advanced POAG patients (vertical cup to disc ratio of 0.9 or more), where the managing consultant recommends either TDLC or medical treatment as primary therapy. 2. All treatment naïve painful blind glaucomatous eyes with elevated IOP where pressure reduction is likely to reduce pain. 3. Adult glaucoma patients aged 18 years and above. 4. Presenting IOP of 28mmHg or more. 5. Known glaucoma patients who have not received any form of glaucoma treatment (medication, laser or trabeculectomy) in the last two months prior to presentation and fulfilling criteria 1-4 above.
Exclusion criteria
Exclusion criteria: 1. Patients with other ocular comorbidities that precludes laser application. 2. Patients who prefer glaucoma medications 3. Patients with uncontrolled systemic diseases like Hypertension, Diabetes mellitus etc. 4. Patients below the age of 18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome was mean intra ocular pressure, IOP, post intervention in both groups as well as percentage reduction in IOP from baseline in the two treatment groups | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes for the trial were complication rates, proportion of patients satisfied with treatment as well as proportion of patients loosing two or Snellens lines of presenting visual acuity in the two treatment groups | — |
Countries
Nigeria
Contacts
Public ContactLawan Abdu
Professor Of ophthalmology. MBBS. Msc CEH. MD. FWACS. FMCOphth
Outcome results
None listed